Skip to main content

5 articles related to "Ent Kaurane"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Mini Review

Published on 29 Jun 2023

Ent-kaurane diterpenoids from the Annonaceae family: a review of research progress and call for further research

in Ethnopharmacology

Traore S. Ibrahim
Purevdulam Khongorzul
Moses Muyaba
Raphael N. Alolga

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1227574

7,335 views
13 citations

Mini Review

Published on 09 Feb 2023

Recent advances in oridonin derivatives with anticancer activity

in Medicinal and Pharmaceutical Chemistry

Pedro J. M. Sobral
André T. S. Vicente
Jorge A. R. Salvador

Frontiers in Chemistry

doi 10.3389/fchem.2023.1066280

7,882 views
20 citations

Review

Published on 03 Dec 2024

Enhancing cancer therapy: advanced nanovehicle delivery systems for oridonin

in Pharmacology of Anti-Cancer Drugs

Yilin Su
Lisha Liu
Chongyang Lin
Dashi Deng
Yunfei Li
Mou Huang
Yu Wang
Kangqiu Ling
Haobing Wang
Qiyu Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1476739

3,323 views
4 citations

Original Research

Published on 06 Sep 2021

Vegetation History in a Peat Succession Over the Past 8,000 years in the ISM-Controlled Kedarnath Region, Garhwal Himalaya: Reconstruction Using Molecular Fossils

in Quaternary Science, Geomorphology and Paleoenvironment

Sharmila Bhattacharya
Harsh Kishor
Yadav Ankit
Praveen K. Mishra
Pradeep Srivastava

Frontiers in Earth Science

doi 10.3389/feart.2021.703362

4,003 views
9 citations

Original Research

Published on 14 Aug 2019

Oridonin Sensitizes Cisplatin-Induced Apoptosis via AMPK/Akt/mTOR-Dependent Autophagosome Accumulation in A549 Cells

in Pharmacology of Anti-Cancer Drugs

Huahong Yang
Yun Gao
Xiaoye Fan
Xingkai Liu
Liping Peng
Xinxin Ci

Frontiers in Oncology

doi 10.3389/fonc.2019.00769

9,350 views
58 citations